Table: begin end state 1 20 cytoplasmic 21 41 transmembrane 42 47 non-cytoplasmic 48 70 transmembrane 71 91 cytoplasmic 92 114 transmembrane 115 125 non-cytoplasmic 126 144 transmembrane 145 154 cytoplasmic 155 176 transmembrane 177 195 non-cytoplasmic 196 215 transmembrane 216 235 cytoplasmic 236 255 transmembrane 256 284 non-cytoplasmic 285 312 transmembrane 313 332 cytoplasmic 333 353 transmembrane 354 358 non-cytoplasmic 359 383 transmembrane 384 391 cytoplasmic 392 413 transmembrane 414 418 non-cytoplasmic 419 437 transmembrane 438 449 cytoplasmic
Input: >Pf6N2E2_2179 FitnessBrowser__pseudo6_N2E2:Pf6N2E2_2179 MSIEAFGYKQELKRGLSLTDLVVYGMIFMIPIAPFGVYGYVNAEAPGMVPLAYIIGMVAM LFTALSYGSMARAFPVAGSVYSYAQRGLNPHVGFIAGWLMLLDYLLIPPLLYVYASMALN HLYPDIPKVGFILAFLVSATFVNLRGITFTARMNIIFLLAQLVVLGIFLFYAWNALHGGA GNGQLTLAPLYSPEHFNFALLMQAVSIAVLSFLGFDAISTLAEEIKGDPGRSVGKAALVT LLVMGAIFVVQTWIATDLAAGMGFKSADTAFYEIAELAAGSWLATLTAVATALAWGVAVA ITSQAAVSRLLFGMARDGQLPKVLAKVHPTHNTPYLSIYLVAVLSLLICYLFIDAVDTLT SLVNFGALSGFMLLHITVINHYWRRQQSGQLIRHLICPLVGFVIVAAIMYNMGVAAQKLG LIWIAAGVIYLCVLNKFGNPTAVPDPAGQ
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server